| A DNA metalloenzyme with DNA ligase activity B Cuenoud, JW Szostak Nature 375 (6532), 611-614, 1995 | 582 | 1995 |
| In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5, 6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled β2 … C Battram, SJ Charlton, B Cuenoud, MR Dowling, RA Fairhurst, D Farr, ... Journal of Pharmacology and Experimental Therapeutics 317 (2), 762-770, 2006 | 221 | 2006 |
| Conformation-dependent cleavage of staphylococcal nuclease with a disulfide-linked iron chelate. MR Ermacora, JM Delfino, B Cuenoud, A Schepartz, RO Fox Proceedings of the National Academy of Sciences 89 (14), 6383-6387, 1992 | 190 | 1992 |
| Dual recognition of double‐stranded DNA by 2′‐aminoethoxy‐modified oligonucleotides B Cuenoud, F Casset, D Hüsken, F Natt, RM Wolf, KH Altmann, P Martin, ... Angewandte Chemie International Edition 37 (9), 1288-1291, 1998 | 180 | 1998 |
| Altered specificity of DNA-binding proteins with transition metal dimerization domains B Cuenoud, A Schepartz Science 259 (5094), 510-513, 1993 | 179 | 1993 |
| Site-specific cleavage of the protein calmodulin using a trifluoperazine-based affinity reagent A Schepartz, B Cuenoud Journal of the American Chemical Society 112 (8), 3247-3249, 1990 | 161 | 1990 |
| Lipid membrane interactions of indacaterol and salmeterol: do they influence their pharmacological properties? D Lombardi, B Cuenoud, SD Krämer European Journal of Pharmaceutical Sciences 38 (5), 533-547, 2009 | 117 | 2009 |
| A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6‐month RCT M Fortier, CA Castellano, V St‐Pierre, É Myette‐Côté, F Langlois, M Roy, ... Alzheimer's & Dementia 17 (3), 543-552, 2021 | 112 | 2021 |
| The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist F Baur, D Beattie, D Beer, D Bentley, M Bradley, I Bruce, SJ Charlton, ... Journal of medicinal chemistry 53 (9), 3675-3684, 2010 | 110 | 2010 |
| A new strategy for directed protein cleavage B Cuenoud, TM Tarasow, A Schepartz Tetrahedron letters 33 (7), 895-898, 1992 | 101 | 1992 |
| Dual recognition of double-stranded DNA by 2 ‘-aminoethoxy-modified oligonucleotides: the solution structure of an intramolecular triplex obtained by NMR spectroscopy MJJ Blommers, F Natt, W Jahnke, B Cuenoud Biochemistry 37 (51), 17714-17725, 1998 | 91 | 1998 |
| Targeted gene knockout by 2′-O-aminoethyl modified triplex forming oligonucleotides N Puri, A Majumdar, B Cuenoud, F Natt, P Martin, A Boyd, PS Miller, ... Journal of Biological Chemistry 276 (31), 28991-28998, 2001 | 89 | 2001 |
| Cell cycle modulation of gene targeting by a triple helix-forming oligonucleotide A Majumdar, N Puri, B Cuenoud, F Natt, P Martin, A Khorlin, N Dyatkina, ... Journal of Biological Chemistry 278 (13), 11072-11077, 2003 | 88 | 2003 |
| Combinations of formoterol and a tiotropium salt IF Hassan, JG Clarke, B Cuenoud US Patent 6,537,524, 2003 | 79 | 2003 |
| Nutritional Ketosis Increases NAD+/NADH Ratio in Healthy Human Brain: An in Vivo Study by 31P-MRS L Xin, Ö Ipek, M Beaumont, M Shevlyakova, N Christinat, M Masoodi, ... Frontiers in nutrition 5, 62, 2018 | 74 | 2018 |
| Targeting of an interrupted polypurine: polypyrimidine sequence in mammalian cells by a triplex-forming oligonucleotide containing a novel base analogue A Semenyuk, E Darian, J Liu, A Majumdar, B Cuenoud, PS Miller, ... Biochemistry 49 (36), 7867-7878, 2010 | 70 | 2010 |
| Design of a metallo-bZIP protein that discriminates between CRE and AP1 target sites: selection against AP1. B Cuenoud, A Schepartz Proceedings of the National Academy of Sciences 90 (4), 1154-1159, 1993 | 66 | 1993 |
| Stable DNA triple helix formation using oligonucleotides containing 2 ‘-aminoethoxy, 5-propargylamino-U M Sollogoub, RAJ Darby, B Cuenoud, T Brown, KR Fox Biochemistry 41 (23), 7224-7231, 2002 | 64 | 2002 |
| Minimum Number of 2‘-O-(2-Aminoethyl) Residues Required for Gene Knockout Activity by Triple Helix Forming Oligonucleotides N Puri, A Majumdar, B Cuenoud, F Natt, P Martin, A Boyd, PS Miller, ... Biochemistry 41 (24), 7716-7724, 2002 | 61 | 2002 |
| Catalytic DNA having ligase activity JW Szostak, B Cuenoud, DE Huizenga US Patent 5,910,408, 1999 | 59 | 1999 |
